Details
| Stereochemistry | EPIMERIC |
| Molecular Formula | C62H89CoN13O15P.HO |
| Molecular Weight | 1363.3625 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 13 / 14 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[OH-].C[C@@H]1CNC(=O)CC[C@]2(C)[C@@H](CC(N)=O)C3[N-]4C2=C(C)C5=[N]6C(=CC7=[N]8C(=C(C)C9=[N]([C@]3(C)[C@@](C)(CC(N)=O)[C@@H]9CCC(N)=O)[Co+3]468(O)[N]%10=C[N@@]([C@H]%11O[C@H](CO)[C@@H](OP([O-])(=O)O1)[C@H]%11O)C%12=C%10C=C(C)C(C)=C%12)[C@@](C)(CC(N)=O)[C@@H]7CCC(N)=O)C(C)(C)[C@@H]5CCC(N)=O
InChI
InChIKey=CDMWPHIGTNJOQY-FBTIOKFQSA-J
InChI=1S/C62H90N13O14P.Co.2H2O/c1-29-20-39-40(21-30(29)2)75(28-70-39)57-52(84)53(41(27-76)87-57)89-90(85,86)88-31(3)26-69-49(83)18-19-59(8)37(22-46(66)80)56-62(11)61(10,25-48(68)82)36(14-17-45(65)79)51(74-62)33(5)55-60(9,24-47(67)81)34(12-15-43(63)77)38(71-55)23-42-58(6,7)35(13-16-44(64)78)50(72-42)32(4)54(59)73-56;;;/h20-21,23,28,31,34-37,41,52-53,56-57,76,84H,12-19,22,24-27H2,1-11H3,(H15,63,64,65,66,67,68,69,71,72,73,74,77,78,79,80,81,82,83,85,86);;2*1H2/q;+4;;/p-4/t31-,34-,35-,36-,37+,41-,52-,53-,56?,57+,59-,60+,61+,62+;;;/m1.../s1
| Molecular Formula | HO |
| Molecular Weight | 17.0073 |
| Charge | -1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C62H89CoN13O15P |
| Molecular Weight | 1346.3551 |
| Charge | 1 |
| Count |
|
| Stereochemistry | EPIMERIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 13 / 14 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 08:50:37 GMT 2023
by
admin
on
Sat Dec 16 08:50:37 GMT 2023
|
| Record UNII |
8S07EB1568
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
LOINC |
1888-7
Created by
admin on Sat Dec 16 08:50:37 GMT 2023 , Edited by admin on Sat Dec 16 08:50:37 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
m6116
Created by
admin on Sat Dec 16 08:50:37 GMT 2023 , Edited by admin on Sat Dec 16 08:50:37 GMT 2023
|
PRIMARY | |||
|
8S07EB1568
Created by
admin on Sat Dec 16 08:50:37 GMT 2023 , Edited by admin on Sat Dec 16 08:50:37 GMT 2023
|
PRIMARY | |||
|
13422-52-1
Created by
admin on Sat Dec 16 08:50:37 GMT 2023 , Edited by admin on Sat Dec 16 08:50:37 GMT 2023
|
PRIMARY | |||
|
AQUACOBALAMIN
Created by
admin on Sat Dec 16 08:50:37 GMT 2023 , Edited by admin on Sat Dec 16 08:50:37 GMT 2023
|
PRIMARY | Description: Dark red crystals or a red, crystalline powder; odourless. Solubility: Sparingly soluble in water and ethanol (~750 g/l) TS; practically insoluble in acetone RCategory: Antianaemia drug. Storage: Hydroxocobalamin should be kept in a tightly closed container, protected from light and stored at a temperature between 2? and 8?C.Labelling: The designation on the container should state whether the substance is in the anhydrous or hydrated form. Additional information: In aqueous solution, Hydroxocobalamin exists as hydroxocobamide in equilibrium with the hydrated ionic form. The anhydrous form of Hydroxocobalamin is very hygroscopic. Even in the absence of light, it is gradually degraded on exposure to a humid atmosphere, the decomposition being faster at higher temperatures. | ||
|
236-534-8
Created by
admin on Sat Dec 16 08:50:37 GMT 2023 , Edited by admin on Sat Dec 16 08:50:37 GMT 2023
|
PRIMARY | |||
|
15852
Created by
admin on Sat Dec 16 08:50:37 GMT 2023 , Edited by admin on Sat Dec 16 08:50:37 GMT 2023
|
PRIMARY |